Related Experiment Video
Updated: Oct 14, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
A Step Toward Health Equity for Veterans: Evidence Supports Removing Race From Kidney Function Calculations
, Cheryl K Conner1, Bijal Jain1
1and are Attending Physicians; is the Section Chief for Hospital Medicine; is an Inpatient Pharmacy Clinical Pharmacy Specialist; is a Nurse Practitioner Section of Palliative Care; and is Facility Transplant Coordinator; all at the Jesse Brown Veterans Affairs Medical Center in Chicago, Illinois. is an Internal Medicine Resident; and Bijal Jain and Natasha Nichols are Assistant Professors, Department of Medicine; and all at Northwestern University Feinberg School of Medicine. Marci Laragh, Cheryl Conner and Ambareen Khan are Clinical Assistant Professors of Medicine, and Sheryl Lowery is Adjunct Clinical Assistant Professor School of Pharmacy; all at the University of Illinois at Chicago.
Background:
The practice of race-based medicine fails to recognize that race cannot be used as a proxy for genetic ancestry and that racial and ethnic categories are complex sociopolitical constructs without biological basis. Clinical algorithms and equations that incorporate race modifiers and are currently considered standard for diagnosis and management of disease are appropriately being scrutinized for lack of biological plausibility and their role in exacerbating health inequities. In this paper, we review the history, evidence, and implications of using a Black race coefficient when calculating estimated glomerular filtration rate (eGFR) in the diagnosis and management of kidney disease.
Observations:
Currently, the US Department of Veterans Affairs (VA) uses the Modification of Diet in Renal Disease (MDRD) equation for eGFR. This equation includes a Black race coefficient that results in an eGFR that is 21% higher for a Black patient when compared with a patient of any other race. The rationale for the inclusion of this coefficient is based on racist science that incorrectly assumes race as a proxy for genetic ancestry. Multiple studies across diverse Black populations demonstrate that the application of a race coefficient in kidney function estimation equations is inferior when compared with the race-neutral option. Furthermore, the most utilized eGFR equations are biased and imprecise. Because eGFR is the primary diagnostic method for detecting and managing kidney disease, preventing its progression, planning for dialysis, and evaluating for transplantation, it is vital that eGFR be as accurate, precise, and equitable as possible.
Conclusions:
The incorporation of a race coefficient in kidney estimation equations lacks biological plausibility and its use exacerbates kidney health disparities. Until a better method to estimate kidney function becomes available, a race-neutral option for current estimation equations should be applied for all patients.
More Related Videos
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Kidney Transplant I: Introduction
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...

